CryoPort, Inc.
As of Oct 22, 2026, CryoPort is in Stage 2, the uptrend phase, now in week 24 (since May 8, 2026). It closed at $17.83, 3.8% below its 52-week high and above its 200-day average, which is rising.
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. More about the company
Pro read
ProOur read
Setup score
Momentum
Edge
Setup-score rank among Stage 2 peers: #1 of 6 in Integrated Freight & Logistics · #1 of 152 in Industrials
Is CYRX early, or has it already run? Pro answers that for every US stock we cover, after every close.
Renews monthly until you cancel. Cancel any time in Plan & billing.
CYRX among Integrated Freight & Logistics3rd of 32 by relative strength
All 32 →| # | Stock | Stage | RS | 1M |
|---|---|---|---|---|
| 1 | BTOC | Stage 2 · wk 2 | 99 | +935.2% |
| 2 | NCEW | Stage 2 · wk 4 | 98 | +0.9% |
| 3 | CYRX | Stage 2 · wk 24 | 92 | +1.9% |
| 4 | EXPD | Stage 2 · wk 22 | 90 | +4.3% |
| 5 | FDX | Stage 3 · wk 5 | 89 | +4.3% |
| 6 | PBI | Stage 3 · wk 7 | 88 | +7.8% |
| 7 | RLGT | Stage 2 · wk 1 | 84 | +0.3% |
| 8 | JBHT | Stage 3 · wk 9 | 80 | −1.7% |
CryoPort: quick answers
What stage is CryoPort in?
As of Oct 22, 2026, CryoPort (CYRX) is in Stage 2, the uptrend phase. It entered Stage 2 on May 8, 2026 and is in week 24. What the four stages mean
Is CryoPort in an uptrend?
Yes. CryoPort is in a Stage 2 uptrend. It trades 36.3% above its 200-day average, which is rising.
How far is CryoPort from its 52-week high?
CryoPort closed at $17.83 on Oct 22, 2026, 3.8% below its 52-week high of $18.53. Its 52-week low is $7.72.
How has CryoPort performed over the past year?
As of Oct 22, 2026, CryoPort is up 75.7% over the past year and up 86.5% so far in 2026.
Which sector and industry is CryoPort in?
CryoPort is in the Integrated Freight & Logistics industry, part of the Industrials sector.
About this companyIndustrials· Integrated Freight & Logistics
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Visit company website →All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.